Milton C. Ault III - Jun 14, 2021 Form 3 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
3
Date filed
6/14/2021, 07:55 PM
Next filing
Jun 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALZN Common Stock 10M Jun 14, 2021 By Ault Life Sciences Fund, LLC F1
holding ALZN Common Stock 3.09M Jun 14, 2021 By Digital Power Lending, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALZN Warrants Jun 14, 2021 Common Stock 5M $3.00 By Ault Life Sciences Fund, LLC F1
holding ALZN Warrants Jun 14, 2021 Common Stock 1.35M $3.00 By Digital Power Lending, LLC F2
holding ALZN Series A Convertible Preferred Stock Jun 14, 2021 Common Stock 15M By Ault Life Sciences, Inc. F3
holding ALZN Stock Options (Right to Buy) Jun 14, 2021 Common Stock 2.5M $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
F2 Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH") Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
F3 The Series A Convertible Preferred Stock (the "Series A Preferred Stock") shall automatically convert into 15,000,000 shares of Common Stock upon the closing of the initial public offering without payment of further consideration. Mr. Ault has sole voting and investment power with respect to the shares of Series A Preferred Stock held of record by Ault Life Sciences, Inc.
F4 Mr. Ault was granted stock options to purchase 2,500,000 shares of Common Stock, which options are exercisable at an exercise price of $0.004 and are currently vested and exercisable.